Finally, we confirm the involvement of the α1A-AR subtype in AD by demonstrating decreased expression in the human amyloid precursor protein (hAPP) AD mouse model and reversal of this deficit by prolonged incubation with CCF219B, which modulates α1A-AR expression levels in a positive feedback loop. Here, APP is linked to Alzheimer disease.